Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-02Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
-
CLINICAL_TRIALS study record update · 2026-01-30A Phase II Study of Radiotherapy to the Prostate and Dose Intensification to the Dominant Intra- Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
-
CLINICAL_TRIALS study record update · 2026-01-30Optimisation and Safety of an Innovative Nuclear Medicine Treatment: Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
-
CLINICAL_TRIALS study record update · 2026-01-30Continence, Sexual and Metabolic Health Programming to Promote Prostate Cancer Wellness for Life (CONTROL4LIFE)
-
CLINICAL_TRIALS study record update · 2026-01-30Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise (ADHERE): A Randomised Controlled Trial Comparing the Efficacy of a Digital Exercise Intervention With Virtual Supervised Group Exercise Sessions to Standard of Care on Exercise Adherence at Six Months in Patients With Prostate Cancer Undergoing Hormone Therapy.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-30Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
-
CLINICAL_TRIALS study record update · 2026-01-30Role of Geriatric Intervention in Treatment of Older Patients With Cancer : a Phase III Randomized Study (PREPARE)
-
CLINICAL_TRIALS study record update · 2026-01-30Phase II Study of Pembrolizumab in Combination With Radiation With or Without Olaparib in Localized High-risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-30Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve-Sparing Radical Prostatectomy Versus Standard of Care
-
CLINICAL_TRIALS study record update · 2026-01-30ClinicalTrials.gov study NCT02886546
-
CLINICAL_TRIALS study record update · 2026-01-29Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
-
CLINICAL_TRIALS study record update · 2026-01-29The Development and Validation of MRI-AI-based Predictive Models for csPCa
-
CLINICAL_TRIALS study record update · 2026-01-29Optimal Prostate Fractionation Study
-
CLINICAL_TRIALS study record update · 2026-01-29A Pilot Study of 18F-DCFPyL-PSMA PET in Patients Receiving 177Lu-Vipivotide Tetraxetan Therapy for Metastatic Castrate-resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-29A Phase III Randomized Study of Low Dose Rate Compared to High Dose Rate Prostate Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-29IMPROVING QUALITY OF LIFE AFTER OPTIMAL RADIOTHERAPY FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER: A Randomized Comparison of HDR Versus LDR BRACHYTHERAPY BOOST
-
CLINICAL_TRIALS study record update · 2026-01-29A Phase I/Ib, Single Arm Study of Two Fraction Stereotactic Body Radiation Therapy (SBRT) With Dominant Lesion Simultaneous Integrated Boost (SIB) for the Treatment of Low to Intermediate Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-29Improving Health Literacy in African-American Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-01-28Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
-
CLINICAL_TRIALS study record update · 2026-01-28Phase I/II Trial of Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-28A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-28HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-01-27The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-26Comparative Study on Imaging Characteristics of Different ⁶⁸Ga-Labeled PSMA Probes in Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-01-26A Phase 1b, Open-label, Multicenter Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Subjects With High-risk Biochemical Recurrence of Nonmetastatic Castration-sensitive Prostate Cancer After Definitive Therapy